Cronobacter sakazakii
| Cronobacter sakazakii | |
|---|---|
| Colonies on trypticase soy broth agar | |
| Scientific classification | |
| Domain: | Bacteria |
| Kingdom: | Pseudomonadati |
| Phylum: | Pseudomonadota |
| Class: | Gammaproteobacteria |
| Order: | Enterobacterales |
| Family: | Enterobacteriaceae |
| Genus: | Cronobacter |
| Species: | C. sakazakii |
| Binomial name | |
| Cronobacter sakazakii (Farmer et al. 1980) | |
Cronobacter sakazakii, which before 2007 was named Enterobacter sakazakii, is an opportunistic Gram-negative, rod-shaped, pathogenic bacterium that can live in very dry places, a phenomenon known as xerotolerance. C. sakazakii utilizes a number of genes to survive desiccation and this xerotolerance may be strain specific. Most C. sakazakii cases are adults but low-birth-weight preterm neonates and older infants are at the highest risk. The pathogen is a rare cause of invasive infection in infants, with historically high case fatality rates (40–80%).
All Cronobacter species, except C. condimenti, have been linked retrospectively to clinical cases of infection in either adults or infants. However multilocus sequence typing has shown that most neonatal meningitis cases in the past 30 years, across six countries, have been associated with only one genetic lineage of the species Cronobacter sakazakii called 'Sequence Type 4' or 'ST4', and therefore this clone appears to be of greatest concern with infant infections.
The bacterium is ubiquitous, being isolated from a range of environments and foods; the majority of Cronobacter cases occur in the adult population. However it is the association with intrinsically or extrinsically contaminated powdered formula which has attracted the main attention. According to multilocus sequence analysis (MLSA) the genus originated ~40 MYA, and the most clinically significant species, C. sakazakii, was distinguishable ~15-23 MYA.